Cantor Fitzgerald analyst Pablo Zuanic maintained a Buy rating on Green Thumb Industries (GTBIF – Research Report) yesterday and set a price target of $41.00. The company’s shares closed last Tuesday at $13.04, close to its 52-week low of $12.90.
Zuanic has an average return of 19.1% when recommending Green Thumb Industries.
According to TipRanks.com, Zuanic is ranked #944 out of 7885 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Green Thumb Industries with a $41.48 average price target.
Green Thumb Industries’ market cap is currently $3.05B and has a P/E ratio of 38.81.
Based on the recent corporate insider activity of 82 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GTBIF in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 12 states and operates over 30 cannabis stores under the chains Rise and Essence. Green Thumb is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including Dr. Solomon’s, Dogwalkers, and Beboe.
Read More on GTBIF: